- Home
- BLRX vs CCHH Comparison
BLRX vs CCHH Comparison
Compare BLRX & CCHH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | BLRX | CCHH |
|---|---|---|
| Founded | 2003 | 2015 |
| Country | Israel | Malaysia |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | |
| Sector | Health Care | |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 12.6M | 10.2M |
| IPO Year | 2010 | N/A |
Fundamental Metrics
Financial Performance| Metric | BLRX | CCHH |
|---|---|---|
| Price | $3.10 | $0.40 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 2 | 0 |
| Target Price | ★ $19.00 | N/A |
| AVG Volume (30 Days) | 22.9K | ★ 70.3K |
| Earning Date | 05-26-2026 | 05-12-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | ★ N/A | $43.55 |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $2.15 | $0.36 |
| 52 Week High | $7.77 | $15.39 |
Technical Indicators
Market Signals| Indicator | BLRX | CCHH |
|---|---|---|
| Relative Strength Index (RSI) | 60.68 | 31.59 |
| Support Level | $2.66 | $0.36 |
| Resistance Level | $3.11 | $0.68 |
| Average True Range (ATR) | 0.25 | 0.04 |
| MACD | 0.04 | -0.00 |
| Stochastic Oscillator | 72.00 | 8.45 |
Price Performance
Historical ComparisonAbout BLRX BioLineRx Ltd.
BioLine Rx Ltd is a commercial-stage biopharmaceutical company focused on oncology. The company's current development and commercialization pipeline consists of two clinical-stage therapeutic candidates motixafortide (BL-8040), a novel peptide for the treatment of stem-cell mobilization and solid tumors, and AGI-134, an immuno-oncology agent in development for solid tumors. In addition, the company has a legacy therapeutic product called BL-5010 for the treatment of skin lesions. The company has generated revenues from milestone payments under previously existing out-licensing agreements.
About CCHH CCH Holdings Ltd Ordinary Shares
CCH Holdings Ltd operates a hotpot restaurant chain in Malaysia, specializing in chicken hotpot and fish head hotpot, mainly under two brand, namely Chicken Claypot House and Zi Wei Yuan, owned by the wholly owned subsidiaries of the Company. The Company conducts its operations through its wholly owned subsidiaries in Malaysia and is engaged as a restaurant operator, licensor and loyalty owner, and general trader. Currently, the Group has developed a restaurant chain including approximately 15 company-owned restaurant outlets, 13 franchised restaurant outlets in Malaysia, and 4 franchised restaurant outlets outside Malaysia.